kin-3248
·Code: KIN-3248
kin-3248: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| KINNATE BIOPHARMA INC. (KNTE) | Phase 1 |
Clinical Trials (1)
A Phase 1/1b, Open-label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
Frequently asked questions
Who is developing kin-3248?
kin-3248 is being developed by KINNATE BIOPHARMA INC..
How many clinical trials involve kin-3248?
BioSniper tracks 1 clinical trial involving kin-3248.
Get deeper analysis on kin-3248
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis